Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026)

Entera Bio (ENTX) recorded quarterly Exchange Rate Effect of $4000.0 in Q1 2026, up 106.15% on a QoQ basis from -$65000.0 in Q4 2025.

Entera Bio (ENTX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Entera Bio has disclosed Exchange Rate Effect across 2 years of filings, most recently posting $4000.0 for Q1 2026.

Quarterly Exchange Rate Effect changed N/A year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61000.0 (changed N/A YoY) and the FY2025 annual result came in at -$36000.0, changed N/A from the prior year.
Exchange Rate Effect grew to $4000.0 in Q1 2026, from -$65000.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at $4000.0 in Q1 2026 and troughed at -$65000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FX Effect (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	3.60 Mn
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-2.70 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-40.30 Mn
9	Abivax	94.37 Bn	94.37 Bn	-	8.68 Mn
10	Entera Bio	56.59 Mn	52.45 Mn	-	4,000.00

Download Data